ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,300, issued on Sept. 23, was assigned to NANJING UNIVERSITY (Jiangsu, China).
"Preparation method and application of single-chain antibody fragment targeting SARS-CoV-2 nucleocapsid protein" was invented by Yi Luo (Jiangsu, China), Wenjin Hu (Jiangsu, China), Shixiang Yang (Jiangsu, China), Xiaolong Wang (Jiangsu, China), Shengyang Wang (Jiangsu, China), Huai Lin (Jiangsu, China) and Xiang Long (Jiangsu, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a preparation method and application of a single-chain antibody fragment targeting SARS-CoV-2 nucleocapsid protein, aiming to provide a single-chain antibody fragment with high affi...